Zacks Investment Research upgraded shares of HMS (NASDAQ:HMSY) from a sell rating to a hold rating in a research note issued to investors on Thursday.
According to Zacks, “HMS Holdings Corp. is a leading provider of cost containment solutions in the U.S. healthcare marketplace. Using innovative technology as well as extensive data services and powerful analytics, the Company delivers coordination of benefits, payment integrity, and health management and member engagement solutions to help customers recover improper payments; prevent future improper payments; reduce fraud, waste and abuse; effectively engage their members and better manage the care they receive; and ensure regulatory compliance. The Company serves commercial health plans, state government agencies, federal programs, at-risk providers, pharmacy benefit managers and employers. “
HMSY has been the topic of a number of other research reports. BidaskClub cut HMS from a buy rating to a hold rating in a report on Wednesday, January 16th. Cantor Fitzgerald reiterated a hold rating and issued a $34.00 target price on shares of HMS in a report on Friday, February 22nd. ValuEngine cut HMS from a strong-buy rating to a buy rating in a report on Monday, December 17th. Finally, William Blair restated an outperform rating on shares of HMS in a research note on Thursday. Five analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. HMS has a consensus rating of Buy and a consensus price target of $33.50.
Shares of HMS stock opened at $32.06 on Thursday. HMS has a twelve month low of $16.29 and a twelve month high of $38.15. The firm has a market capitalization of $2.74 billion, a P/E ratio of 38.17, a PEG ratio of 3.02 and a beta of 1.64. The company has a debt-to-equity ratio of 0.34, a quick ratio of 4.40 and a current ratio of 4.40.
HMS (NASDAQ:HMSY) last issued its earnings results on Friday, February 22nd. The business services provider reported $0.28 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.25 by $0.03. HMS had a return on equity of 14.21% and a net margin of 9.19%. The firm had revenue of $155.80 million for the quarter, compared to analysts’ expectations of $155.84 million. During the same quarter last year, the firm earned $0.24 earnings per share. The firm’s revenue for the quarter was up 4.9% compared to the same quarter last year. As a group, equities research analysts predict that HMS will post 0.97 EPS for the current year.
In related news, insider Meredith W. Bjorck sold 67,689 shares of the business’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $33.58, for a total value of $2,272,996.62. Following the transaction, the insider now owns 61,759 shares in the company, valued at $2,073,867.22. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Jeffrey Scott Sherman sold 268,426 shares of the business’s stock in a transaction dated Thursday, February 28th. The stock was sold at an average price of $34.55, for a total value of $9,274,118.30. Following the completion of the transaction, the chief financial officer now owns 218,253 shares in the company, valued at approximately $7,540,641.15. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 971,526 shares of company stock worth $33,510,192. 4.54% of the stock is currently owned by insiders.
Several large investors have recently added to or reduced their stakes in the stock. BlackRock Inc. lifted its stake in shares of HMS by 2.1% in the fourth quarter. BlackRock Inc. now owns 12,449,568 shares of the business services provider’s stock worth $350,208,000 after acquiring an additional 260,935 shares in the last quarter. Vanguard Group Inc. increased its holdings in HMS by 2.7% in the third quarter. Vanguard Group Inc. now owns 8,382,915 shares of the business services provider’s stock valued at $275,045,000 after buying an additional 216,531 shares during the last quarter. Vanguard Group Inc increased its holdings in HMS by 2.7% in the third quarter. Vanguard Group Inc now owns 8,382,915 shares of the business services provider’s stock valued at $275,045,000 after buying an additional 216,531 shares during the last quarter. Standard Life Aberdeen plc increased its holdings in HMS by 8.8% in the fourth quarter. Standard Life Aberdeen plc now owns 1,677,850 shares of the business services provider’s stock valued at $47,341,000 after buying an additional 135,599 shares during the last quarter. Finally, Norges Bank bought a new stake in HMS in the fourth quarter valued at about $42,907,000. Institutional investors and hedge funds own 95.19% of the company’s stock.
HMS Company Profile
HMS Holdings Corp., through its subsidiaries, provides cost containment solutions in the United States healthcare marketplace. It provides coordination of benefits services to government and commercial healthcare payers and sponsors to coordinate benefits for claims; and payment integrity services that ensure healthcare claims billed are accurate and appropriate, as well as offers care management and consumer engagement solutions.
Recommended Story: Why are percentage decliners important?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HMS and related companies with MarketBeat.com's FREE daily email newsletter.